Epivir (Lamivudine) - Adverse Event Reports - Other Serious Reactions - Drug Exposure During Pregnancy

Adverse event in 27 year old female receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from Germany on 2007-07-18

Patient: 27 year old female

Adverse reactions / side effects: Cholestasis of Pregnancy, Drug Exposure During Pregnancy, Proteus Infection, Anogenital Warts, Genital Infection

Suspect drug(s):
Combivir
    Dosage: 900mg per day
    Administration route: Oral
    Start date: 2005-02-16

Epivir
    Dosage: 300mg per day
    Administration route: Oral
    Start date: 2004-07-29
    End date: 2005-02-16

Fuzeon
    Dosage: 180mg per day
    Start date: 2005-03-22
    End date: 2005-03-31

Invirase
    Dosage: 2000mg per day
    Start date: 2004-09-29
    End date: 2005-02-16

Norvir
    Dosage: 400mg per day
    Start date: 2004-07-29
    End date: 2005-02-16

Viread
    Dosage: 300mg per day
    Start date: 2004-07-29

Adverse event in 28 year old female receiving Epivir (Lamivudine)

Reported by a consumer/non-health professional from France on 2007-06-25

Patient: 28 year old female

Adverse reactions / side effects: Drug Exposure During Pregnancy, Drug Dependence, Treatment Noncompliance

Suspect drug(s):
Epivir
    Administration route: Oral
    Indication: HIV Infection

Morphine
    Administration route: Oral

Retrovir
    Administration route: Oral
    Indication: HIV Infection

Viracept
    Administration route: Oral
    Indication: HIV Infection

Adverse event in female receiving Epivir (Lamivudine)

Reported by a consumer/non-health professional from United States on 2007-06-14

Patient: female

Adverse reactions / side effects: Electroencephalogram Abnormal, Cerebral Disorder, Drug Exposure During Pregnancy, Rhinitis, Neutropenia, Foetal Growth Retardation, Anaemia Macrocytic

Adverse event resulted in: hospitalization

Suspect drug(s):
Crixivan
    Dosage: ongoing gestational week 2 through 10
    Indication: HIV Test Positive
    Start date: 1997-05-29
    End date: 1997-07-01

Epivir
    Dosage: initiated at gestational week 29
    Indication: HIV Test Positive
    Start date: 1997-11-12
    End date: 1998-01-19

Epivir
    Dosage: 6 week course after birth
    Administration route: Oral
    Indication: Prophylaxis Against HIV Infection
    Start date: 1998-01-01
    End date: 1998-03-01

Fortovase
    Dosage: initiated at gestational week 29
    Indication: HIV Test Positive
    Start date: 1997-11-12
    End date: 1998-01-19

Retrovir
    Dosage: initiated at gestational week 10
    Indication: HIV Test Positive
    Start date: 1997-07-01
    End date: 1998-01-19

Retrovir
    Dosage: infusion at delivery
    Administration route: Oral
    Indication: Prophylaxis Against HIV Infection
    Start date: 1998-01-01
    End date: 1998-03-01

Videx
    Dosage: ongoing at gestational weeks 2 through 10
    Indication: HIV Infection
    Start date: 1997-05-29
    End date: 1997-07-01

Zerit
    Dosage: ongoing gestational weeks 2 through 10
    Indication: HIV Test Positive
    Start date: 1997-05-29
    End date: 1997-07-01

Adverse event in 31 year old female receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-06-07

Patient: 31 year old female, weighing 60.5 kg (133.1 pounds)

Adverse reactions / side effects: Umbilical Cord Abnormality, Drug Exposure During Pregnancy, Intra-Uterine Death, Placental Infarction, Abortion Spontaneous

Suspect drug(s):
Cotrim
    Indication: Prophylaxis
    Start date: 2004-01-01

Didanosine
    Dosage: 250 mg, qd, oral
    Administration route: Oral
    Indication: Retroviral Infection
    Start date: 2004-09-01

Epivir
    Indication: Retroviral Infection

Fuzeon
    Dosage: 90 mg, bid, subcutaneous
    Indication: Retroviral Infection

Lamivudine
    Dosage: 300 mg/day, oral
    Administration route: Oral

Norvir
    Dosage: 100 mg/day, oral
    Administration route: Oral
    Indication: Retroviral Infection

Reyataz(atazanvir)
    Dosage: 300 mg/day, oral
    Administration route: Oral
    Indication: Retroviral Infection

Valganciclovir HCL
    Indication: Cytomegalovirus Test
    Start date: 2004-09-01

Adverse event in 38 year old female receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from France on 2007-05-07

Patient: 38 year old female

Adverse reactions / side effects: Drug Exposure During Pregnancy, Abortion Induced, Cervical Dysplasia, Ectopic Pregnancy

Suspect drug(s):
Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-12-21

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-06-01

Other drugs received by patient: Reyataz; Norvir; Viread; Truvada; Invirase

Adverse event in receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-04-03

Patient:

Adverse reactions / side effects: Vertical Infection Transmission, Drug Exposure During Pregnancy, Human Immunodeficiency Virus Transmission, Maternal Condition Affecting Foetus, Failure TO Thrive, Hepatosplenomegaly

Suspect drug(s):
Epivir
    Dosage: transplacentary
    Indication: Antiviral Prophylaxis

Nevirapine
    Dosage: transplacentary
    Indication: Antiviral Prophylaxis

Quinine Sulfate
    Dosage: transplacentary
    Indication: Plasmodium Falciparum Infection

Retrovir
    Dosage: transplacentary
    Indication: Antiviral Prophylaxis

Adverse event in 32 year old female receiving Epivir (Lamivudine)

Reported by a physician from Botswana on 2007-03-29

Patient: 32 year old female

Adverse reactions / side effects: Drug Exposure During Pregnancy, Congenital Anomaly, Abortion Spontaneous, Ectopic Pregnancy

Suspect drug(s):
Epivir
    Dosage: 300mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-02-13

Sustiva
    Dosage: 600mg per day
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2004-02-13
    End date: 2005-03-18

Viramune
    Dosage: 400mg per day
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2005-03-18

Zerit
    Dosage: 60mg per day
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2004-02-13

Adverse event in 19 year old female receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-01-08

Patient: 19 year old female

Adverse reactions / side effects: Premature Baby, Drug Exposure During Pregnancy, Anaemia

Suspect drug(s):
Epivir
    Dosage: 300mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-06-05

Retrovir
    Dosage: 1mgkh per day
    Indication: HIV Infection
    Start date: 2006-10-24
    End date: 2006-10-24

Zidovudine
    Dosage: 600mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-06-05

Other drugs received by patient: Kaletra; Viracept; Trimethoprim + Sulfamethoxazole; Macrobid; Clotrimazole Troches; Reglan; Promethazine; Cefazolin